Back to
Fédération des caisses Desjardins du Québec
ADCT
5 quarters
Position history for
Fédération des caisses Desjardins du Québec's holdings in ADC Therapeutics SA
No. Fédération des caisses Desjardins du Québec exited its ADCT (ADC Therapeutics) position in Q3 2024. Its Q2 2024 13F listed 20 shares worth $63. Fédération des caisses Desjardins du Québec first reported ADCT in Q3 2023 and held it in 4 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$18
Total Shares Change
-20
Quarter-by-Quarter History
Other major holders of ADCT: FMR LLC